Knight Therapeutics Inc. announced the appointment of Amal Khouri to the position of Vice President of Business Development and the appointment of Sylvie Tendler to the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.75 CAD | +0.52% | +4.93% | +10.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.79% | 423M | |
+4.96% | 70.02B | |
+21.35% | 9.05B | |
-22.81% | 4.43B | |
+14.83% | 4.16B | |
+19.21% | 3.83B | |
-1.86% | 2.06B | |
+8.78% | 2.02B | |
-36.94% | 1.9B | |
-45.25% | 1.71B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Inc. Announces Executive Appointments